JP2024546844A5 - - Google Patents
Info
- Publication number
- JP2024546844A5 JP2024546844A5 JP2024535383A JP2024535383A JP2024546844A5 JP 2024546844 A5 JP2024546844 A5 JP 2024546844A5 JP 2024535383 A JP2024535383 A JP 2024535383A JP 2024535383 A JP2024535383 A JP 2024535383A JP 2024546844 A5 JP2024546844 A5 JP 2024546844A5
- Authority
- JP
- Japan
- Prior art keywords
- approximately
- solid form
- ray powder
- powder diffraction
- form according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163290136P | 2021-12-16 | 2021-12-16 | |
| US63/290,136 | 2021-12-16 | ||
| PCT/US2022/081795 WO2023114995A1 (en) | 2021-12-16 | 2022-12-16 | Solid forms of pyrazolo[3,4-d]pyrimidine compounds |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024546844A JP2024546844A (ja) | 2024-12-26 |
| JP2024546844A5 true JP2024546844A5 (cg-RX-API-DMAC10.html) | 2025-12-04 |
Family
ID=85172741
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024535383A Pending JP2024546844A (ja) | 2021-12-16 | 2022-12-16 | ピラゾロ[3,4-d]ピリミジン化合物の固体形態 |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US12012412B2 (cg-RX-API-DMAC10.html) |
| EP (1) | EP4448529A1 (cg-RX-API-DMAC10.html) |
| JP (1) | JP2024546844A (cg-RX-API-DMAC10.html) |
| KR (1) | KR20240119299A (cg-RX-API-DMAC10.html) |
| CN (1) | CN118401525A (cg-RX-API-DMAC10.html) |
| AU (2) | AU2022416644B2 (cg-RX-API-DMAC10.html) |
| CA (1) | CA3242577A1 (cg-RX-API-DMAC10.html) |
| IL (1) | IL313314A (cg-RX-API-DMAC10.html) |
| MX (1) | MX2024007517A (cg-RX-API-DMAC10.html) |
| TW (1) | TW202333676A (cg-RX-API-DMAC10.html) |
| WO (1) | WO2023114995A1 (cg-RX-API-DMAC10.html) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2024546844A (ja) | 2021-12-16 | 2024-12-26 | ファイザー・インク | ピラゾロ[3,4-d]ピリミジン化合物の固体形態 |
| WO2025043067A2 (en) * | 2023-08-22 | 2025-02-27 | Cardurion Pharmaceuticals, Inc. | Pyrazolo[3,4-d]pyrimidinone compounds for the treatment of chronic heart failure |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4522811A (en) | 1982-07-08 | 1985-06-11 | Syntex (U.S.A.) Inc. | Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides |
| PT2152712E (pt) | 2007-05-11 | 2012-02-29 | Pfizer | Compostos amino-heterocíclicos |
| CN109893653A (zh) * | 2017-12-11 | 2019-06-18 | 王慧敏 | Pde9抑制剂的新用途 |
| JP2024546844A (ja) * | 2021-12-16 | 2024-12-26 | ファイザー・インク | ピラゾロ[3,4-d]ピリミジン化合物の固体形態 |
-
2022
- 2022-12-16 JP JP2024535383A patent/JP2024546844A/ja active Pending
- 2022-12-16 US US18/082,622 patent/US12012412B2/en active Active
- 2022-12-16 CA CA3242577A patent/CA3242577A1/en active Pending
- 2022-12-16 EP EP22854339.3A patent/EP4448529A1/en active Pending
- 2022-12-16 MX MX2024007517A patent/MX2024007517A/es unknown
- 2022-12-16 AU AU2022416644A patent/AU2022416644B2/en active Active
- 2022-12-16 TW TW111148528A patent/TW202333676A/zh unknown
- 2022-12-16 IL IL313314A patent/IL313314A/en unknown
- 2022-12-16 CN CN202280083751.7A patent/CN118401525A/zh active Pending
- 2022-12-16 KR KR1020247023041A patent/KR20240119299A/ko active Pending
- 2022-12-16 WO PCT/US2022/081795 patent/WO2023114995A1/en not_active Ceased
-
2024
- 2024-05-06 US US18/655,795 patent/US20240300961A1/en active Pending
-
2025
- 2025-12-03 AU AU2025275149A patent/AU2025275149A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022540668A5 (cg-RX-API-DMAC10.html) | ||
| JP2015533168A5 (cg-RX-API-DMAC10.html) | ||
| FI4157832T3 (fi) | Glp-1r-agonistien suola- ja kidemuotoja ja niiden käyttötarkoituksia | |
| CA1155116A (en) | Phenyl piperazine derivatives having antiagressive activity | |
| RU2016101964A (ru) | СТИМУЛЯТОРЫ sGC | |
| JP2022542803A5 (cg-RX-API-DMAC10.html) | ||
| TWI359803B (en) | Tetraphenylnaphthalene derivatives and organic lig | |
| JP2025511847A5 (cg-RX-API-DMAC10.html) | ||
| JP2023546125A5 (cg-RX-API-DMAC10.html) | ||
| JP2024508526A5 (cg-RX-API-DMAC10.html) | ||
| RU2014122261A (ru) | Форма iv ивабрадина гидрохлорида | |
| CZ302591B6 (cs) | 2´-Substituované 1,1´-bifenyl-2-karboxamidy, jejich použití a farmaceutické prostredky, které je obsahují | |
| JP2007533672A5 (cg-RX-API-DMAC10.html) | ||
| JP2024502178A5 (cg-RX-API-DMAC10.html) | ||
| CA2626451A1 (en) | Cyclopropylacetic acid derivatives and use thereof | |
| JPS59118783A (ja) | 新規の置換された1,4−ジヒドロピリジン、その製造法及びこれを診断剤として使用する方法 | |
| CA2488193A1 (en) | Inhibitors of the gpib -vwf interaction, their preparation and use | |
| JP2024514090A5 (cg-RX-API-DMAC10.html) | ||
| JP4319148B2 (ja) | S−(−)−アムロジピンニコチネート及びその製造方法 | |
| JP2022540678A5 (cg-RX-API-DMAC10.html) | ||
| US20080293781A1 (en) | Salicylic Acid Derivatives | |
| JP2005504795A5 (cg-RX-API-DMAC10.html) | ||
| WO2016145622A1 (zh) | 苯并咪唑衍生物及其制备方法和医药用途 | |
| JP2013540780A (ja) | イミダゾール誘導体並びにその製造法及び使用 | |
| US4250316A (en) | Pyridyl guanidine anti-ulcer agents |